Physician profile
Amy D Sharp
NPI 1063813418
$2,286.27
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $791 · 2022: $924 · 2023: $544 · 2024: $28.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $903.89 | 2021-2023 | |
| Pfizer INC. | $196.13 | 2021-2023 | |
| Novo Nordisk INC | $178.96 | 2022-2023 | Wegovy |
| Exeltis, USA INC. | $154.05 | 2021-2023 | Slynd |
| Hologic Sales and Service, LLC | $146.03 | 2022 | |
| Sumitomo Pharma America, INC. | $125.50 | 2023-2024 | Myfembree |
| Amgen INC. | $124.97 | 2021 | |
| Mayne Pharma Commercial LLC | $122.10 | 2022 | |
| Evofem Biosciences, INC. | $97.71 | 2021-2022 | |
| Medtronic, INC. | $94.88 | 2022-2023 | Bis |
| Daiichi Sankyo INC. | $36.80 | 2022 | |
| Therapeuticsmd, INC. | $29.74 | 2021 | |
| Alexion Pharmaceuticals, INC. | $23.53 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $20.40 | 2023 | Seglentis |
| Agile Therapeutics, INC. | $18.55 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.03 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.